Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05462639 |
|---|---|
| Brief Title: | Elranatamab Expanded Access Protocol in Adults With Relapsed/Refractory Multiple Myeloma (MAGNETISMM17) |
| First Submitted : | June 20, 2022 |
| First Submitted that Met QC Criteria : | July 15, 2022 |
| First Posted : | July 18, 2022 |
| Last Update Submitted that Met QC Criteria : | September 8, 2023 |
| Last Update Posted : | September 11, 2023 |